Literature DB >> 20978477

Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors.

Nicole M Kane1, Ali Nowrouzi, Sayandip Mukherjee, Michael P Blundell, Jenny A Greig, Wai Kwong Lee, Miles D Houslay, Graeme Milligan, Joanne C Mountford, Christof von Kalle, Manfred Schmidt, Adrian J Thrasher, Andrew H Baker.   

Abstract

Retroviral vectors remain the most efficient and widely applied system for induction of pluripotency. However, mutagenic effects have been documented in both laboratory and clinical gene therapy studies, principally as a result of dysregulated host gene expression in the proximity of defined integration sites. Here, we report that cells with characteristics of pluripotent stem cells can be produced from normal human fibroblasts in the absence of reprogramming transcription factors (TFs) during lentiviral (LV) vector-mediated gene transfer. This occurred via induced alterations in host gene and microRNA (miRNA) expression and detrimental changes in karyotype. These findings demonstrate that vector-induced genotoxicity may alone play a role in somatic cell reprogramming derivation and urges caution when using integrating vectors in this setting. Clearer understanding of this process may additionally reveal novel insights into reprogramming pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978477      PMCID: PMC2997595          DOI: 10.1038/mt.2010.231

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  36 in total

1.  Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo.

Authors:  Nicole M Kane; Marco Meloni; Helen L Spencer; Margaret A Craig; Raimund Strehl; Graeme Milligan; Miles D Houslay; Joanne C Mountford; Costanza Emanueli; Andrew H Baker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

2.  Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

Authors:  Olga Kustikova; Boris Fehse; Ute Modlich; Min Yang; Jochen Düllmann; Kenji Kamino; Nils von Neuhoff; Brigitte Schlegelberger; Zhixiong Li; Christopher Baum
Journal:  Science       Date:  2005-05-20       Impact factor: 47.728

3.  Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.

Authors:  Shi-Lung Lin; Donald C Chang; Samantha Chang-Lin; Chun-Hung Lin; David T S Wu; David T Chen; Shao-Yao Ying
Journal:  RNA       Date:  2008-08-28       Impact factor: 4.942

4.  Generation of induced pluripotent stem cells from neural stem cells.

Authors:  Jeong Beom Kim; Holm Zaehres; Marcos J Araúzo-Bravo; Hans R Schöler
Journal:  Nat Protoc       Date:  2009-09-17       Impact factor: 13.491

5.  Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.

Authors:  Elayne M Chan; Sutheera Ratanasirintrawoot; In-Hyun Park; Philip D Manos; Yuin-Han Loh; Hongguang Huo; Justine D Miller; Odelya Hartung; Junsung Rho; Tan A Ince; George Q Daley; Thorsten M Schlaeger
Journal:  Nat Biotechnol       Date:  2009-10-11       Impact factor: 54.908

6.  Telomerase reverse transcriptase related with telomerase activity regulates tumorigenic potential of mouse embryonic stem cells.

Authors:  Ki Dae Park; Su Kyoung Seong; Yang Mook Park; Youngju Choi; Jae Hyun Park; Sang-Hun Lee; Dae Hyun Baek; Jin Wook Kang; Kyoung Suk Choi; Sue Nie Park; Dong Sup Kim; Seung Hee Kim; Hyung Soo Kim
Journal:  Stem Cells Dev       Date:  2010-11-05       Impact factor: 3.272

7.  Comprehensive genomic access to vector integration in clinical gene therapy.

Authors:  Richard Gabriel; Ralph Eckenberg; Anna Paruzynski; Cynthia C Bartholomae; Ali Nowrouzi; Anne Arens; Steven J Howe; Alessandra Recchia; Claudia Cattoglio; Wei Wang; Katrin Faber; Kerstin Schwarzwaelder; Romy Kirsten; Annette Deichmann; Claudia R Ball; Kamaljit S Balaggan; Rafael J Yáñez-Muñoz; Robin R Ali; H Bobby Gaspar; Luca Biasco; Alessandro Aiuti; Daniela Cesana; Eugenio Montini; Luigi Naldini; Odile Cohen-Haguenauer; Fulvio Mavilio; Adrian J Thrasher; Hanno Glimm; Christof von Kalle; William Saurin; Manfred Schmidt
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

Review 8.  Progress toward the clinical application of patient-specific pluripotent stem cells.

Authors:  Evangelos Kiskinis; Kevin Eggan
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

10.  Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability.

Authors:  Paul W Burridge; David Anderson; Helen Priddle; Maria D Barbadillo Muñoz; Sarah Chamberlain; Cinzia Allegrucci; Lorraine E Young; Chris Denning
Journal:  Stem Cells       Date:  2006-12-21       Impact factor: 6.277

View more
  25 in total

Review 1.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

Review 2.  Mechanism and methods to induce pluripotency.

Authors:  Peizhe Wang; Jie Na
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

3.  The stem cell "tunnel" effect.

Authors:  Thomas P Zwaka
Journal:  Mol Ther       Date:  2010-12       Impact factor: 11.454

Review 4.  Genetic therapy for the nervous system.

Authors:  William J Bowers; Xandra O Breakefield; Miguel Sena-Esteves
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

5.  Transcriptome transfer provides a model for understanding the phenotype of cardiomyocytes.

Authors:  Tae Kyung Kim; Jai-Yoon Sul; Nataliya B Peternko; Jae Hee Lee; Miler Lee; Vickas V Patel; Junhyong Kim; James H Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

6.  iPSCs: Unstable origins?

Authors:  Sayandip Mukherjee; Adrian J Thrasher
Journal:  Mol Ther       Date:  2011-07       Impact factor: 11.454

Review 7.  Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Taruna Anand; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

8.  Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.

Authors:  Helen E Chick; Ali Nowrouzi; Raffaele Fronza; Robert A McDonald; Nicole M Kane; Raul Alba; Christian Delles; William C Sessa; Manfred Schmidt; Adrian J Thrasher; Andrew H Baker
Journal:  Hum Gene Ther       Date:  2012-10-26       Impact factor: 5.695

Review 9.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.

Authors:  Chuanfeng Wu; Cynthia E Dunbar
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

10.  Control and prevention of myocardial fibrosis using Pyk2-related non-kinase.

Authors:  Kai You; Yi Huang; Ming-Can Zhang; Jia Hao
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.